Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Net Income towards Common Stockholders (2016 - 2026)

Avanos Medical's Net Income towards Common Stockholders history spans 11 years, with the latest figure at -$300000.0 for Q4 2024.

  • On a quarterly basis, Net Income towards Common Stockholders rose 40.0% to -$300000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was -$300000.0, a 95.0% increase, with the full-year FY2024 number at -$5.8 million, up 88.82% from a year prior.
  • Net Income towards Common Stockholders hit -$300000.0 in Q4 2024 for Avanos Medical, up from -$1.6 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for AVNS hit a ceiling of $38.5 million in Q2 2021 and a floor of -$63.8 million in Q2 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$4.6 million across 5 years, with a median of -$400000.0 in 2023.
  • Biggest five-year swings in Net Income towards Common Stockholders: skyrocketed 1383.33% in 2021 and later tumbled 928.57% in 2023.
  • Tracing AVNS's Net Income towards Common Stockholders over 5 years: stood at -$49.0 million in 2020, then surged by 47.55% to -$25.7 million in 2021, then soared by 128.02% to $7.2 million in 2022, then tumbled by 106.94% to -$500000.0 in 2023, then soared by 40.0% to -$300000.0 in 2024.
  • Business Quant data shows Net Income towards Common Stockholders for AVNS at -$300000.0 in Q4 2024, -$1.6 million in Q3 2024, and -$2.5 million in Q2 2024.